Screening of coding region of metastasis suppressor genes KISS1 and KAI-1 for germ line mutations in breast cancer patients

Gene Therapy and Molecular Biology

Volumn 12, Issue 2, 2008, Pages 239-246

  Malik, Fraz Arshad ^a,b   Kayani, Mahmood Akhter ^a   Iqbal, Hina ^a   Jiang, Wen G ^b   Sadiq, Rafshan ^c  

^a Department of Electrical Computer Engineering   (Pakistan)

^b CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

^c PUNJAB MEDICAL COLLEGE   (Pakistan)

Author keywords

KAI1; KISS1; Single strand Conformational polymorphism; Sporadic breast cancer; SSCP

Indexed keywords

EID: 69549101412     PISSN: 15299120     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Anderson D, Yu TW, Dobrzyńska MM, Ribas G, Marcos R (1998) Effects in the comet assay of storage conditions on human blood. Teratog Carcinog Mutagen 17, 115-125.
2. Briese J, Schulte HM, Sajin M, Bamberger C, Redlin K, Milde-Langosch K, Löning, T, Bamberger AM (2008) Correlations between reduced expression of the metastasis suppressor gene KAI-1 and accumulation of p53 in uterine carcinomas and sarcomas. Virchows Archiv 453, 89-96.
3. Farhadieh RD, Smee R, Ow K, Yang JL, Russell PJ, Crouch R, Jackson P, Jacobson. (2004) Downregulation of KAI1/CD82 protein expression in oral cancer correlates with reduced disease free survival and overall patient survival. Cancer Lett 213, 91-98.
4. Gasser RB (1997) Mutation scanning methods for the analysis of parasite genes. Int J Parasitol 27, 1449-1463.
5. Goldberg SF, Miele ME, Hatta N, Takata M, Paquette-Straub C, Freedman LP, Welch DR (2003) Melanoma metastasis suppression by chromosome 6: evidence for a pathway regulated by CRSP3 and TXNIP. Cancer Res Jan 63, 432-440.
6. Guénard F, Labri Y, Ouellette G, Beauparlant CJ, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Pichette R, Plante M, Durocher F (2007) INHERIT BRCAs: Germ line mutations in the breast cancer susceptibility gene PTEN are rare in high-risk non-BRCA1/2 French Canadian breast cancer families. Fam Cancer 6, 483-490.
7. Guan-Zhen Y, Ying C, Can-Rong N, Guo-Dong W, Jian-Xin Q, Jie-Jun W (2007) Reduced protein expression of metastasisrelated genes (nm23, KISS1, KAI1 and p53) in lymph node and liver metastases of gastric cancer. Int J Exp Pathol 88, 175-183.
8. Houle CD, Ding XY, Foley JF, Afshari CA, Barrett JC, Davis BJ (2002) Loss of expression and altered localization of KAI1 and CD9 protein are associated with epithelial ovarian cancer progression. Gynecol Oncol 86, 69-78.
9. Hsieh SM, Lintell NA, Hunter KW (2006) Germ line polymorphisms are potential metastasis risk and prognosis markers in breast cancer. Breast Dis 26, 157-162.
10. Huang H, Groth J, Sossey-Alaoui K, Hawthorn L, Beall S, Geradts J (2005) Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumours. Clin Cancer Res 11, 4357-4364.
11. Ichikawa T, Ichikawa Y, Dong J, Hawkins AL, Griffin CA, Isaacs WB, Oshimura M, Barrett JC, Isaacs JT (1992) Localization of metastasis suppressor gene(s) for prostatic cancer to the short arm of human chromosome 11. Cancer Res 52, 3486-3490.
12. Ikeguchi M, Yamaguchi KI, Kaibara N (2004) Clinical Significance of the Loss of KiSS-1 and Orphan G-Protein-Coupled Receptor (hOT7T175) Gene Expression in Esophageal Squamous Cell Carcinoma. Clin Cancer Res 10, 1379-1383.
13. Jackson P, Ow K, Yardley G, Delprado W, Quinn DI, Yang JL, Russell PJ (2003) Downregulation of KAI1mRNA in localized prostate cancer and its bony metastases do not correlate with p53 over expression. Prostate Cancer Prostatic Dis 6, 174-181.
14. Jackson P, Rowe A, Grimm MO (2007) An alternatively spliced KAI1 mRNA is expressed at low levels in human bladder cancers and bladder cancer cell lines and is not associated with invasive behaviour. Oncol Rep 18,1357-63
15. Karges B, de Roux N (2005) Molecular genetics of isolated hypogonadotropic hypogonadism and Kallmann syndrome. Endocr Dev 8, 67-80.
16. Nash KT, Welch DR (2006) The KISS1 metastasis suppressor: mechanistic insights and clinical utility. Front Biosci 11, 647-659.
17. Köchl S, Niederstätter H, Parson W (2005) DNA extraction and quantitation of forensic samples using the phenol-chloroform method and real-time PCR. Methods Mol Bio 297, 13-30.
18. Kukita Y, Tahira T, Sommer SS, Hayashi K (1997) SSCP analysis of long DNA fragments in low pH gel. Hum Mutat 10, 400-7.
19. Lallas TA, Buller RE (1998) SSCP techniques in BRCA1 analysis. Molec Genet Metab 64, 173-176.
20. Lee JH, Miele ME, Hicks DJ, Phillips KK, Trent J M, Weissman BE, Welch DR (1996) KiSS-1, a novel human malignant melanoma metastasis-suppressor gene. J Nat Cancer Inst 88, 1731-1737.
21. Lee JH, Park SR, Chay KO, Seo YW, Kook H, Ahn KY, Kim YJ and Kim (2004) KAI1 COOH-Terminal interacting Tetraspanin (KITENIN), a member of the tetraspanin family, interacts with KAI1, a tumor metastasis suppressor and enhances metastasis of cancer. Cancer Res 64, 4235-4243.
22. Liu FS, Dong JT, Chen JT, Hsieh YT, Ho ES, Hung MJ (2000) Frequent down-regulation and lack of mutation of the KAI1 metastasis suppressor gene in epithelial ovarian carcinoma. Gynecol Oncol 78, 10-15.
23. Malik F, Sanders AJ, Douglas-Jones A, Mansel RE, Jiang WG (2008) Kai-1 is aberrant expressed in human breast cancer and its link with cancer invasiveness. Brit J Cancer in press.
24. Marreiros A, Dudgeon K, Dao V, Grimm MO, Czolij R, Crossley M, Jackson P (2005) KAI1 promoter activity is dependent on p53, junB and AP2: evidence for a possible mechanism underlying loss of KAI1 expression in cancer cells. Oncogene 20, 637-49.
25. Martin TA, Watkins G, Jiang WG (2005) KiSS-1 expression in human breast cancer. Clin Exp Metastasis 22, 503-511.
26. Martins CMO, Fernandes BF, Antecka E, Di Cesare, S, Mansure JJC, Marshall J-C, Burnier MN (2008) Expression of the metastasis suppressor gene KISS1 in uveal melanoma. Eye 22, 707-711.
27. Mashimo T, Watabe M, Hirota S, Hosobe S, Miura K, Tegtmeyer P J, Rinker-Shaeffer C W, Watabe K (1998) The expression of the KAI1 gene, a tumor metastasis suppressor, is directly activated by p53. Proc Nat Acad Sci 95, 11307-11311.
28. Meyer A, Dörk T, Sohn C, Karstens JH, Bremer M (2007) Breast cancer in patients carrying a germ line CHEK2 mutation: Outcome after breast conserving surgery and adjuvant radiotherapy. Radiother Oncol 82, 349-353.
29. Miyazaki T, Kato H, Shitara Y, Yoshikawa M,Tajima K, Masuda N, Shouji H, Tsukada K, Nakajima T, Kuwano H (2000) Mutation and expression of the metastasis suppressor gene KAI1 in esophageal squamous cell carcinoma. Cancer 89, 955-962.
30. Nagira M, Imai T, Ishikawa I, Uwabe KI, Yoshie O (2005) Mouse homologue of C33 antigen (CD82), a member of the transmembrane 4 superfamily: complementary DNA, genomic structure, and expression. Cell Immunol 157, 144-157.
31. Nollau P and Wagener C (1997) Methods for detection of point mutations: performance and quality assessment. Clin Chem 43, 114-1128.
32. Odintsova E, Sugiura T, Berditchevski F (2000) Attenuation of EGF receptor signaling by a metastasis suppressor, the tetraspanin CD82/KAI-1. Curr Biol 4, 1009-11.
33. Rouille Y, Duguay SJ, Lund K, Furuta M, Gong Q, Lipkind G, Oliva AA Jr, Chan SJ, Steiner DF (1995) Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides: the subtilisin-like proprotein convertases. Front Neuroendocrinol 16, 322-361.
34. Rubin H (2001) Selected Cell and Selective Microenvironment in Neoplastic Development. Cancer Res 61, 799-807.
35. Sanchez-Carbayo M, Capodieci P, Cordon-Cardo C (2003) Tumor suppressor role of KiSS-1 in bladder cancer - Loss of KiSS-1 expression is associated with bladder cancer progression and clinical outcome. Am J Pathol 162, 609-617.
36. Schindi M, Birner P, Bachtiary B, Breitenecker G, Selzer E, Oberhuber G (2000) The impact of expression of the metastasis suppressor protein KAI1 on prognosis in invasive squamous cell cervical cancer. Anticancer Res 20, 4551-5.
37. Sho M, Adachi M, Taki T, Hashida H, Konishi T, Huang C-L, Ikeda N, Nakajima Y, Kanehiro H, Hisanaga M, Nakano H, Miyake M (1998) Transmembrane 4 superfamily as a prognostic factor in pancreatic cancer. Int J Cancer 79, 509-516.
38. Stafford LJ, Vaidya KS, Welch DR (2008) Metastasis suppressors genes in cancer. Int J Biochem Cell Biol 40, 874-891.
39. Stark AM, Tongers K, Maass N, Mehdorn HM, Held-Feindt J (2005) Reduced metastasis-suppressor gene mRNAexpression in breast cancer brain metastases. J Cancer Res Clin Oncol 131, 191-198.
40. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge J E, Liotta L A, Sobel M E (1998) Evidence for a novel gene associated with a low tumor metastatic potential. J Nat Cancer Inst 80, 200-204.
41. Terao Y, Kumano S, Takatsu Y, Hattori M, Nishimura A, Ohtaki T, Shintani Y (2004) Expression of KiSS-1, a metastasis suppressor gene, in trophoblast giant cells of the rat placenta. Biochim Biophys Acta 1678, 102-110.
42. Tonoli H and Barrett JC (2005) CD82 metastasis suppressor gene: A potential target for new therapeutics? Trends Mol Med 11, 563-570
43. Tsutsumi S, Shimura T, Morinaga N, Mochiki E, Asao T, Kuwano H (2005) Loss of KAI1 expression in gastric cancer. Hepato-Gastroenterol 52, 281-284.
44. Wang XY, Liu T, Zhu CZ, Li Y, Sun R, Sun CY, Wang AX (2005) Expression of KAI1, MRP-1, and FAK proteins in lung cancer detected by high-density tissue microarray. Aizheng (Chin J Cancer) 24, 1091-1095.
45. White A, Lamb PW, and Barrett JC (1998) Frequent down regulation of the KAI1 (CD82) metastasis suppressor protein in human cancer cell lines. Oncogene 16, 3143-3149.
46. Yang JM, Peng ZH, Si SH, Liu WW, Luo YH, Ye ZY (2008) KAI1 gene suppresses invasion and metastasis of hepatocellular carcinoma MHCC97-H cells in vitro and in animal models. Liver Int 28, 132-139.